Skip to record
ExecutivesCarmine N. Stengone

Executive record

Carmine N. Stengone

Director at KIORA PHARMACEUTICALS INC

Follow record
More
Challenge a Claim

Alpha ID: alpha:person:carmine-stengoneVersion: public-0As of: 2026-10-03

Not yet claimed10 published Claims4 sources
  • Director

Leadership, in context.

Connect capital, control, accountability, and evidence.

Published Claims10Within this recordEvidence sources4Inspect provenance and dates

Explore the record

ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.

Key Claims

Biography

Mr. Stengone is President, CEO and board member of Contineum Therapeutics, Inc. (Nasdaq: CTNM). He has over 20 years of experience as an executive in the life science industry, having founded, operated, financed and negotiated strategic alliances for multiple companies. Previously served as President and CEO of Avelas Biosciences and held positions at Phenomix Corporation, Anadys Pharmaceuticals and Johnson & Johnson.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.